Gqg Partners LLC Dexcom Inc Transaction History

Gqg Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $88,571 - $111,043	-682 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$106.71 - $143.18 $72,776 - $97,648	682 New	682 $373,000
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $52.6 Million - $70.4 Million	-673,838 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $7.06 Million - $8.35 Million	73,942 Added 12.33%	673,838 $278 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $8.35 Million - $14 Million	133,152 Added 28.53%	599,896 $243 Million
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $22.3 Million - $35.3 Million	466,744 New	466,744 $126 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Gqg Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Gqg Partners LLC with notifications on news.